Concepedia

Author

Michael Pantze

Roche (Switzerland)

Also Known As

Michael P. Pantze, Michael Pantze

9

Publications

862

Citations

7

H-Index

17

Concepts

All Affiliations

Roche (Switzerland)La Roche College
MP

About

Michael Pantze is an author at Roche (Switzerland) specializing in medicine, pharmacology, and dermatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

294

2

Pharmacology

3

3

294

3

Allergy

1

1

39

4

Immunology

1

1

135

5

Drug Discovery

1

1

135

Michael Pantze

×

7

Publications

855

Citations

7

H-Index

YearCitations

Cholestatic Potential of Troglitazone as a Possible Factor Contributing to Troglitazone-Induced Hepatotoxicity: In Vivo and in Vitro Interaction at the Canalicular Bile Salt Export Pump (Bsep) in the Rat

Christoph Funk, Christiane Ponelle, Gerd Scheuermann,

Molecular Pharmacology

2001

290

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao,

Drug Metabolism and Disposition

2005

219

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

Yanan Zheng, Devin B. Tesar, Lisa J. Benincosa,

mAbs

2012

135

The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition

Ashok Rakhit, Michael Pantze, Scott Fettner,

European Journal of Clinical Pharmacology

2007

120

Anti-Inflammatory Properties of Docosahexaenoic and Eicosapentaenoic Acids in Phorbol-Ester-lnduced Mouse Ear Inflammation

Daniel Raederstorff, Michael Pantze, Heinrich Bachmann,

International Archives of Allergy and Immunology

1996

39

Cholestatic Potential of Troglitazone as a Possible Factor Contributing to Troglitazone-Induced Hepatotoxicity: In Vivo and in Vitro Interaction at the Canalicular Bile Salt Export Pump (Bsep) in the Rat

Christoph Funk, Christiane Ponelle, Gerd Scheuermann,

Molecular Pharmacology

2001

37

Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer

Hilary Calvert, Chris Twelves, Malcolm Ranson,

Anti-Cancer Drugs

2014

15

Page 1